Research AboutOfferDocumentationLoginBook a demo
ResearchAboutOfferLoginBook a demo

Concept Life Sciences

Ownership
Private
Employees
~500
Therapeutic Areas
ImmunologyOncologyGastroenterologyNeurology
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculeProteinPeptideOligonucleotideCell therapyGene therapyAntibody-drug conjugatecustom peptide synthesistargeted protein degradationprodrugstherapeutic antibody development

Concept Life Sciences General Information

Concept Life Sciences is not a drug developer but has supported the advancement of at least: ~44 candidates to preclinical stage, ~28–30 candidates to clinic, ~4–5 drugs to market for its clients as of recent reporting.

Contact Information

Website
https://www.conceptlifesciences.com/
Primary Industry
Contract Research Organization
Corporate Office
Sandwich, England
United Kingdom

Drug Pipeline

No pipeline data available

For full access to Concept Life Sciences's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Concept Life Sciences Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Concept Life Sciences's complete valuation and funding history, request access »

Concept Life Sciences Financial Metrics

See full profile
Book a demo
OverviewDrug PipelineTechnologiesPartnershipsFundingCompetitorsAnalysisPatentsLicensing Deals